It stressed there were no issues with "clinical efficacy or safety, trial design, labelling, or manufacturing" that could suggest a lengthy delay. The EU approval is based on the results of the ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...